2 Juicy Biotech Stocks to Consider Buying Right Now

Alex Carchidi, The Motley Fool
·3 min read
2 Juicy Biotech Stocks to Consider Buying Right Now

There are two plays that every biotech investor should know. The first is to buy stock in a company that's very new but that is targeting an unexploited and niche market, typically in the form of a rare and untreated disease. The company has a tightly focused pipeline targeting the muscular disorder space, and its lead program, EDG-5506, is a muscle stabilizer drug intended to treat conditions like Duchenne muscular dystrophy and Becker muscular dystrophy.